Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001567619-18-005081
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-05 16:14:27
Reporting Period:
2018-11-01
Accepted Time:
2018-11-05 16:14:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501989 Cytomx Therapeutics Inc. CTMX Pharmaceutical Preparations (2834) 273521219
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654058 A. Sean Mccarthy 343 Oyster Point Blvd.
Suite 100
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-01 5,370 $1.57 87,433 No 4 M Direct
Common Stock Disposition 2018-11-01 100 $15.01 87,333 No 4 S Direct
Common Stock Disposition 2018-11-01 5,270 $15.00 82,063 No 4 S Direct
Common Stock Acquisiton 2018-11-02 1,156 $1.57 83,219 No 4 M Direct
Common Stock Disposition 2018-11-02 1,156 $15.01 82,063 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-11-01 5,370 $0.00 5,370 $1.57
Common Stock Stock Option (Right to Buy) Disposition 2018-11-02 1,156 $0.00 1,156 $1.57
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
137,227 2025-02-08 No 4 M Direct
136,071 2025-02-08 No 4 M Direct
Footnotes
  1. The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. This option vests in 48 substantially equal monthly installments starting on the last day of January 2015.
  3. This transaction was executed in multiple trades in prices ranging from $15.00 to $15.02, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.